Nanomedicine-Based Therapeutic Strategies for Next-Generation Cancer Immunotherapy

Area of Science:

• Oncology
• Nanomedicine
• Immunology

Background:

• Cancer immunotherapy has revolutionized treatment but has limited clinical success due to poor response rates and tumor penetration.
• Current immunotherapies are often insufficient as standalone treatments.
• Nanomedicine offers diverse therapeutic modalities for cancer treatment.

Purpose of the Study:

• To review advances in nanomedicine-based strategies for cancer treatment.
• To explore the integration of nanomedicine with cancer immunotherapy and regulated cell death pathways.
• To discuss synergistic combination strategies and future perspectives.

Main Methods:

• Literature review of nanomedicine-based cancer therapies.
• Analysis of cancer immunotherapy mechanisms and limitations.
• Examination of regulated cell death pathways in cancer treatment.
• Evaluation of combination strategies involving nanomedicine and immunotherapy.

Main Results:

• Nanomedicine strategies (photothermal, photodynamic, sonodynamic therapy, nanozymes, vaccines) show potential in cancer treatment.
• Integration with immunotherapy or regulated cell death can improve tumor microenvironment modulation and immune response.
• Combination therapies demonstrate synergistic effects in overcoming immunotherapy resistance.

Conclusions:

• Nanomedicine-based strategies hold significant promise for enhancing cancer immunotherapy.
• Combination approaches are crucial for improving therapeutic efficacy and overcoming resistance.
• Further development of nanomedicine platforms is essential for next-generation cancer immunotherapy.